Further reading Books

Ahmed, H. 2005. Principles and Reactions of Protein Extraction, Purification and Characterization. CRC Press.

Carpenter, J. 2002. Rational Design of Stable Protein Formulations. Kluwer.

Costantino, H. and Pikal, M. (eds). 2005. Lyophilization of Biopharmaceuticals. AAPS Press.

Desai, M. 2000. Downstream Protein Processing Methods. Humana Press.

Flickinger, M. 1999. The Encyclopedia of Bioprocess Technology. Wiley.

Frokjaer, S. 2000. Pharmaceutical Formulation Development of Peptides and Proteins. Taylor and Francis. Grindley, J. and Ogden, J. 2000. Understanding Biopharmaceuticals. Manufacturing and Regulatory Issues. Interpharm Press.

Harris, E. 2000. Protein Purification Applications. Oxford University Press.

Merten, O.-W., Mattanovich, D., Lang, C., Larsson, G., Neubauer, P., Porro, D., Postma, P., Teixeira de Mattos, J., and Cole, J.A. Recombinant Protein Production with Prokaryotic and Eukaryotic Cells: A Comparative View on Host Physiology ? Kluwer. Janson, J. 1998. Protein Purification. Wiley.

Oxender, D. and Post, L. 1999. Novel Therapeutics from Modern Biotechnology. Springer Verlag. Roe, S. 2001. Protein Purification Techniques. Oxford University Press. Walsh, G. 2002. Proteins: Biochemistry and Biotechnology. Wiley.


Arakawa, T., Prestrelski, S.J., Kenney, W.C., and Carpenter, J.F. 2001. Factors effecting short-term and long-term stabilities of proteins. Advanced Drug Delivery Reviews 46, 307-326.

Bernard, A.R., Lusti-Narasimhan, M., Radford, K.M., Hale, R.S., Sebille, E., and Graber, P. 1996. Downstream processing on insect cultures. Cytotechnology 20(1-3), 239-257.

Cleland, J.L., Powell, M.F., and Shire, S.J. 1993. The development of stable protein formulations: a close look at protein aggregation, deamidation and oxidation. Critical Reviews in Therapeutic Drug Carrier Systems 10(4), 307-377.

Frokjaer, S. and Otzen, D. 2005. Protein drug stability: a formulation challenge. Nature Reviews Drug Discovery 4, 298-306.

Hedhammar, M., Graslund, T., and Hober, S. 2005. Protein engineering strategies for selective protein purification. Chemical Engineering and Technology 28, 1315-1325.

Keller, K., Friedmann, T., and Boxman, A. 2001. The bioseparation needs for tomorrow. Trends in Biotechnology 19(11), 438-441.

Lee, J. 2000. Biopharmaceutical formulation. Current Opinion in Biotechnology 11(1), 81-84.

Nikolov, Z. and Woodard, S. 2004. Downstream processing of recombinant proteins from transgenic feedstock. Current Opinion in Biotechnology 15, 479-486.

Shire, S.J., Shahrokh, Z., and Liu J. 2004. Challenges in the development of high protein concentration formulations. Journal of Pharmaceutical Sciences 93, 1390-1402.

Wang, W. 2000. Lyophilizatin and development of solid protein pharmaceuticals. International Journal of Pharmaceutics 203(1-2), 1-60.

Wei, W. 1999. Instability, stabilization and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics 185(2), 129-188.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment